Pediatric oncology is a specialized branch of cancer research focused on diagnosing and treating cancers in children. Unlike adult cancers, pediatric cancers often have distinct biological characteristics, making their treatment and prognosis different. Researchers in this field aim to understand the genetic and molecular drivers of childhood cancers, such as leukemia, brain tumors, and neuroblastoma, to develop more effective, less toxic therapies. Advances in pediatric oncology have led to significant improvements in survival rates, but challenges remain in reducing long-term side effects from treatments. Ongoing studies emphasize precision medicine, genetic therapies, and novel drug development to provide better outcomes for young patients. Collaborative efforts between research institutes, healthcare providers, and families play a crucial role in advancing pediatric oncology and ensuring a brighter future for children battling cancer.
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title : The role of artificial intelligence (AI) in oncology
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates